biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Robert Peterson has been named Chief Financial Officer, effective January 8, 2024.

Biote is a hormone optimization company that has translated over 80 years of scientific insight into clinically-validated medical approaches that identify and treat imbalances in hormone production. 


Biote Names Robert Peterson As Chief Financial Officer

Biote Names Robert Peterson As Chief Financial Officer

Company Info

Related People